Aarno Palotieمشاهده پروفایل
پژوهشگر
- Genomics
- Neurogenetics
- Psychiatric Genetics
- +۷ مورد دیگر
Dr. Aarno Palotie is a Research Director at the Finnish Institute of Molecular Medicine , affiliated with the University of Helsinki. He leads the Center of Excellence in Complex Disease Genetics and serves as a supervisor in multiple doctoral programs including Brain & Mind , Clinical Research , and Population Health . Palotie maintains external affiliations as an Associate Member at the Broad Institute of MIT and Harvard and Group Leader at Massachusetts General Hospital since 2013. Research Focus: The genomics of neurological and neuropsychiatric disorders constitutes Palotie’s core research domain, with specific expertise in biomedical sciences and neurogenetics . His work spans polygenic risk scores for schizophrenia, traumatic brain injury pathways, Alzheimer’s biomarkers , and cardiovascular genetic mechanisms . Recent publications highlight his contributions to metabolomic disease mapping , synaptic pathway analysis , and population-specific genetic architectures . Scientific Recognition: 2022: European Society of Human Genetics (ESHG) Award 2023: Media Industry Award for Health Sector Influence 2016: Helsinki City Science Award 2016/2022: Order of the White Rose of Finland 2022: Honorary Doctorate Academic Engagement: Palotie serves as editorial reviewer for Nature Genetics and Annals of Neurology , and participates in 32 international academic visits . He chairs the Galien Foundation Board (2025-2029) and advises THL (National Institute for Health and Welfare) Finland’s 2025-2029 strategic committee.






